The World Markets Healthcare (WMH) service, which tracks changes in the operating environment for pharma and is offered by GlobalData, a leading intelligence and productivity platform, reached a key milestone on 13 April 2026 when its experienced analyst team delivered its 150,000th analysis.
The milestone was reached with the publication of the report titled “South Korean PREC Recommends Five Drugs for Reimbursement,” written by Chia Hsuan Lin, Senior Pharma Research Analyst at GlobalData—underscoring WMH’s commitment to delivering timely, high-impact intelligence.
On the same day, Managing Analyst Eoin Ryan published his 7,777th analysis, while Managing Analyst Brendan Melck – the team’s daily analysis top individual contributor – published his 9,227th analysis, highlighting the scale, consistency, and depth of expertise behind GlobalData’s market-leading coverage.
Milena Izmirlieva, Head of Health Economics and Market Access Research and Analysis at GlobalData, comments: “These are not just numbers. The sheer volume of analyses, and the fact the analyst team has 10+ years of experience, on average, covering pharma developments in their assigned markets, demonstrates the depth of expertise across the WMH analyst team. The first WMH analysis was published in 2000.”
Same day analysis is a key component of the WMH product offering. The analyst team provides forward-looking analysis of developments impacting the operating environment for the pharma industry across 120 markets. All analyses are categorized and available in a searchable archive, allowing the analyst team and clients to forecast how similar developments are likely to unfold.
A global head of public affairs at a multinational pharmaceutical company says: “WMH makes sure we don’t miss policy developments.”
Izmirlieva adds: “In the complex environment of pharmaceutical policy and regulations – where things change each day and every country is different – the best predictor of future outcomes is often past experience with similar reforms. That makes access to GlobalData’s 25-year daily analysis archive and to our analysts’ expertise critical.”
